Skip to main content

Accounting & Financial Management

By Jeff Lagasse | 12:32 pm | July 24, 2024
Due to the strong performance, the company is forecasting 2024 EPS guidance of $21.60 to $22.80 per share, both improvements.
By Jeff Lagasse | 12:52 pm | July 23, 2024
The plaintiffs claim that Change failed to implement cybersecurity safeguards such as multifactor authentication.
By Jeff Lagasse | 03:41 pm | July 19, 2024
This near-record trend is driven by inflationary pressure, prescription drug spending and behavioral health utilization, the report claims.
By Jeff Lagasse | 01:43 pm | July 17, 2024
Operating revenue was $43.2 billion in the quarter, a decrease of $0.2 billion compared to the prior year quarter.
By Nathan Eddy | 11:49 am | July 17, 2024
Marketing and branding have emerged as the foremost strategic growth priorities, with CFOs saying these areas are critical.
By Jeff Lagasse | 12:15 pm | July 16, 2024
The company said it rebounded after a tough first quarter brought on by the Change cyberattack.
By Jeff Lagasse | 11:28 am | July 05, 2024
Gross margins per enrollee ranged from $753 in the Medicaid managed care market to $1,982 in the MA market.
HIMSS24
By HIMSS TV | 04:22 pm | July 03, 2024
Jorie AI has an automated claims adjudication product to speed up payments, says CEO Sal Lo.  
By HIMSS TV | 06:00 am | July 03, 2024
Massive chain cyberattacks, including those against Change and Ascension, have shed new light on the power of these incidents to trigger multiple cyber insurance policies, says Hartmut Mai, president of Cyberwrite.
By Susan Morse | 12:01 pm | July 01, 2024
The current pharmacy model is unsustainable as Walgreens is in discussions with PBM and payer partners to get paid fairly, CEO says.